An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
J Thromb Haemost
; 21(4): 838-849, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36696185
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antigens, Human Platelet
/
Thrombocytopenia, Neonatal Alloimmune
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Female
/
Humans
/
Male
/
Newborn
/
Pregnancy
Language:
En
Journal:
J Thromb Haemost
Journal subject:
HEMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Reino Unido